cisapride has been researched along with Gastroschisis in 2 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Gastroschisis: A congenital defect with major fissure in the ABDOMINAL WALL lateral to, but not at, the UMBILICUS. This results in the extrusion of VISCERA. Unlike OMPHALOCELE, herniated structures in gastroschisis are not covered by a sac or PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to compare the neonatal postoperative course and morbidity for patients with gastroschisis who received cisapride with those who did not receive cisapride." | 7.70 | Cisapride and caesarean section: their role in babies with gastroschisis. ( Duffy, B; Kumar, RK; Shi, EC, 1999) |
| "The objective of this study was to compare the neonatal postoperative course and morbidity for patients with gastroschisis who received cisapride with those who did not receive cisapride." | 3.70 | Cisapride and caesarean section: their role in babies with gastroschisis. ( Duffy, B; Kumar, RK; Shi, EC, 1999) |
| "Cisapride is a potentially useful therapy in patients with pediatric short-bowel syndrome with gastrointestinal dysmotility." | 2.76 | Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility. ( Duggan, C; Hart, K; Jaksic, T; Jiang, H; Kamin, DS; Nurko, S; Raphael, BP, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raphael, BP | 1 |
| Nurko, S | 1 |
| Jiang, H | 1 |
| Hart, K | 1 |
| Kamin, DS | 1 |
| Jaksic, T | 1 |
| Duggan, C | 1 |
| Kumar, RK | 1 |
| Shi, EC | 1 |
| Duffy, B | 1 |
1 trial available for cisapride and Gastroschisis
| Article | Year |
|---|---|
Cisapride improves enteral tolerance in pediatric short-bowel syndrome with dysmotility.
Topics: Child; Child, Preschool; Cisapride; Citrulline; Energy Intake; Enteral Nutrition; Enterocolitis, Nec | 2011 |
1 other study available for cisapride and Gastroschisis
| Article | Year |
|---|---|
Cisapride and caesarean section: their role in babies with gastroschisis.
Topics: Australia; Cesarean Section; Cisapride; Comorbidity; Cryptorchidism; Female; Follow-Up Studies; Gast | 1999 |